MiD expression is increased in PASMC from patients with PAH, and this upregulation of MiD49 and MiD51 increases fission and promotes a hyperproliferative, apoptosis-resistant, cancer-like PAH phenotype (Figure 8) [20]. Here, MIEF1 is linked to pulmonary arterial hypertension.